Michael Gapen, Morgan Stanley chief U.S. economist; Subadra Rajappa, Societe General head of U.S. rates strategy; and Jamie ...

Steve Liesman, JPMorgan’s David Kelly, Wolfe’s Stephanie Roth and Morgan Stanley’s Jim Caron, join 'Power Lunch' to discuss ...

Morgan Stanley closed 0.36% below its 52-week high of $139.04, which the company reached on January 24th.

Michael Grimes, a technology banker with Morgan Stanley , is in talks to leave the bank for a position in U.S. President ...

The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.

The brokerage said a slowdown in growth has unnerved investors, but it believes a recovery is on the horizon. The recent price decline has occurred on falling trading volumes, suggesting a lack of ...

Fourth-quarter earnings have lifted the market to all-time highs. Here are 10 stocks that Morgan Stanley is most bullish on ...

Intellia Therapeutics Inc (NTLA) stock saw a decline, ending the day at $10.01 which represents a decrease of $-0.54 or -5.12% from the prior close of $10.55. The stock opened at $10.64 and touched a ...

Morgan Stanley’s traders beat analysts’ estimates in the fourth quarter, joining their other Wall Street rivals in reporting ...

Morgan Stanley Wealth Management today announced results from its quarterly retail investor pulse survey: Majority of ...

Morgan Stanley's proprietary sentiment indicator has gone into buy territory for the first time since mid-2022.  While it can ...

Morgan Stanley expects the Bank of England to cut interest rates five times in 2025 in an attempt to support a stuttering ...